Improved periviability in Japan and dilemmas for non‐communicable diseases in the COVID‐19 era

In reference to my commentary (1), Kono et al (2) correctly distinguish between improvements in mortality and morbidity and lack of significant improvement in cognitive delay among three years old survivors, born at 22 gestational weeks and actively resuscitated during 2003-2012 in Japan. This clarification is well taken.